Atherosclerotic Vascular Disease Associated with Chronic Kidney Disease

Matthew J Tunbridge1, Alan G Jardine2

  • 1Nephrology Department, Royal Brisbane and Women's Hospital, Level 9 Ned Hanlon Building, Butterfield Street, Herston, QLD 4029, Australia; University of Queensland, Mayne Medical Building, 288 Herston Road, Herston, QLD 4029, Australia.

Cardiology Clinics
|July 12, 2021
PubMed

Insights

Cardiovascular risk significantly rises with declining kidney function, especially in end-stage renal disease. Slowing renal decline or transplantation are key to reducing cardiovascular disease in chronic kidney disease patients.

Area of Science:

  • Nephrology and Cardiovascular Medicine
  • Renal Disease Pathophysiology
  • Cardiovascular Risk Stratification

Background:

  • Cardiovascular disease (CVD) risk escalates with decreasing glomerular filtration rate (GFR) in progressive renal disease.
  • Hyperlipidemia is a primary risk factor for atherosclerotic vascular disease (ASVD), a common comorbidity in patients with renal impairment.
  • Dyslipidemia patterns and their association with vascular events become less clear as GFR declines.

Purpose of the Study:

  • To examine the relationship between declining GFR and cardiovascular risk in renal disease.
  • To investigate the challenges in managing dyslipidemia and ASVD in advanced chronic kidney disease (CKD).
  • To identify effective strategies for reducing ASVD in CKD patients.

Main Methods:

  • Review of existing literature on GFR, dyslipidemia, and cardiovascular outcomes in renal disease.
  • Analysis of pathophysiological changes in CKD affecting lipid metabolism and vascular health.
  • Evaluation of therapeutic interventions for ASVD in early, advanced, and end-stage CKD.

Main Results:

  • Cardiovascular risk is maximal in end-stage renal disease patients requiring dialysis.
  • Statin therapy demonstrates reduced effectiveness in advanced and end-stage CKD.
  • Coronary interventions carry a greatly increased risk in CKD patients.

Conclusions:

  • Slowing the decline of renal function is a critical strategy to mitigate ASVD in CKD.
  • Renal transplantation offers a means to restore renal function and potentially reduce cardiovascular risk.
  • Management of cardiovascular risk in advanced CKD requires tailored approaches beyond standard lipid-lowering therapies.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
288
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
200
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
120
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
159
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
4.2K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
105